{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-25-000317","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2025-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.720413+00:00","generated_at":"2026-05-24T11:33:11.260210+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Quest Diagnostics provides long-term outlook: 4-5% revenue CAGR; reaffirms FY2025 guidance but notes Q1 weather headwind","bullets":["Long-term outlook: revenue CAGR 4-5%, adjusted EPS CAGR 7-9% beyond 2025.","Reaffirms FY2025 guidance: revenue $10.70B-$10.85B, adjusted EPS $9.55-$9.80.","Q1 2025 weather headwind of ~$25M revenue and ~$0.10 EPS expected.","Strategic initiatives include Invigorate productivity (3% annual savings) and Project Nova IT modernization.","Double-digit growth targeted in advanced diagnostics: oncology, cardiometabolic, brain health, others."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-25-000317","json":"https://secwatch.observer/filing/0000947871-25-000317.json","markdown":"https://secwatch.observer/filing/0000947871-25-000317.md","text":"https://secwatch.observer/filing/0000947871-25-000317.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000094787125000317/0000947871-25-000317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000094787125000317/ss4592500_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T11:33:11.260210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}